Clinical Trial Update: A Trial Investigating the Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in a Tablet Formulation With Three Different Coatings in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the pharmacokinetics and pharmacodynamics of the tablet formulation NNC0123-0000-0338 with three coatings in healthy subjects has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• NNC0123-0000-0338

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED